Situation:
Dunlap Bennett & Ludwig represented the US Government Health and Human Services (HHS) through the Office of General Counsel (OGC) at the National Institutes of Health (NIH), over a five-year government contract. The task was to safeguard hundreds of US and foreign trademarks for all HHS agencies. This encompassed developing trademark strategy, resolving disputes, and managing applications. Amid this, Dunlap Bennett & Ludwig was called to provide emergency assistance for the CDC’s marks, aiding the US Attorney’s efforts in preventing fraudulent COVID-19 vaccine cards.
Solution:
Dunlap Bennett & Ludwig crafted a tailored trademark strategy for each HHS agency, considering domestic and international trademarks. Dispute resolution strategies were implemented efficiently to maintain the integrity of HHS brands. In the emergency situation with the CDC, DBL collaborated closely with the US Attorney’s office, offering swift legal support to counteract fraudulent use of CDC marks. The focus was on clarity, efficiency, and immediate action to protect public health.
Results:
The collaborative efforts between Dunlap Bennett & Ludwig and HHS yielded successful outcomes on multiple fronts. Over the five-year contract, DBL secured and maintained the protection of hundreds of US and foreign trademarks for all HHS agencies. Dispute resolutions were achieved efficiently, preserving the integrity of HHS brands.
In the emergency work for the CDC, Dunlap Bennett & Ludwig’s legal intervention assisted the US Attorney’s efforts in preventing fraudulent COVID-19 vaccine cards. The quick response and strategic legal support played a crucial role in maintaining the authenticity of CDC marks during a critical public health situation.